Skip to content
10-Q

Quarterly Report

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB

0001299130-26-000081

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 310.6M sh
Shares Diluted Q1 2026 · Mar 31, 2026 305.82M sh
Shares Diluted Q1 2026 · Mar 31, 2025 296.86M sh
Capex Q1 2026 · Mar 31, 2026 $3.04M
Capex Q1 2026 · Mar 31, 2025 $1.39M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$44.69M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$44.06M
Short Term Investments Q1 2026 · Mar 31, 2026 $219.69M
Short Term Investments Q1 2026 · Dec 31, 2025 $215.8M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $56.27M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $63.71M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $58.51M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.37M
Stockholders Equity Q1 2026 · Dec 31, 2025 $5.35M
Stockholders Equity Q1 2026 · Mar 31, 2025 $91.64M
Stockholders Equity Q1 2026 · Dec 31, 2024 $506.59M
Current Liabilities Q1 2026 · Mar 31, 2026 $65.36M
Current Liabilities Q1 2026 · Dec 31, 2025 $72.83M
Total Liabilities Q1 2026 · Mar 31, 2026 $780M
Total Liabilities Q1 2026 · Dec 31, 2025 $778.73M
Current Assets Q1 2026 · Mar 31, 2026 $369.52M
Current Assets Q1 2026 · Dec 31, 2025 $375.05M
Total Assets Q1 2026 · Mar 31, 2026 $782.37M
Total Assets Q1 2026 · Dec 31, 2025 $784.08M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.03
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.44
Eps Basic Q1 2026 · Mar 31, 2026 −$0.03
Eps Basic Q1 2026 · Mar 31, 2025 −$1.44
Sga Expense Q1 2026 · Mar 31, 2026 $31.15M
Sga Expense Q1 2026 · Mar 31, 2025 $40.17M
Rd Expense Q1 2026 · Mar 31, 2026 $19.61M
Rd Expense Q1 2026 · Mar 31, 2025 $29.05M
Net Income Q1 2026 · Mar 31, 2026 −$8.28M
Net Income Q1 2026 · Mar 31, 2025 −$426.08M
Operating Income Q1 2026 · Mar 31, 2026 −$8.36M
Operating Income Q1 2026 · Mar 31, 2025 −$428.93M
Gross Profit Q1 2026 · Mar 31, 2026 $12.84M
Gross Profit Q1 2026 · Mar 31, 2025 −$1.37M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $24.34M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $38.52M
Revenue Q1 2026 · Mar 31, 2026 $37.18M
Revenue Q1 2026 · Mar 31, 2025 $37.15M